Morgan Stanley Hookipa Pharma Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Hookipa Pharma Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,240,072 shares of HOOK stock, worth $793,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,240,072

Previous 1,184,072 4.73%

Holding current value

$793,646

Previous $959,000 8.24%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.61 - $0.83 $34,160 - $46,480	56,000 Added 4.73%	1,240,072 $880,000
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.86 $228,107 - $467,076	543,112 Added 84.73%	1,184,072 $959,000
Q3 2023 Nov 15, 2023	BUY	$0.58 - $0.91 $109,983 - $172,559	189,626 Added 42.01%	640,960 $397,000
Q2 2023 Aug 14, 2023	BUY	$0.71 - $1.97 $146,206 - $405,672	205,925 Added 83.91%	451,334 $397,000
Q1 2023 May 15, 2023	BUY	$0.72 - $1.03 $153,316 - $219,327	212,939 Added 655.8%	245,409 $181,000

Q4 2022 Feb 14, 2023	BUY	$0.73 - $1.31 $6,052 - $10,861	8,291 Added 34.29%	32,470 $26,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $1.87 $79,274 - $116,727	-62,421 Reduced 72.08%	24,179 $32,000
Q2 2022 Oct 27, 2022	BUY	$1.33 - $2.31 $52,815 - $91,732	39,711 Added 84.69%	86,600 $141,000
Q2 2022 Aug 15, 2022	BUY	$1.33 - $2.31 $52,815 - $91,732	39,711 Added 84.69%	86,600 $141,000
Q1 2022 Oct 27, 2022	SELL	$1.26 - $2.52 $50,035 - $100,071	-39,711 Reduced 45.86%	46,889 $107,000
Q1 2022 May 13, 2022	SELL	$1.26 - $2.52 $87,688 - $175,376	-69,594 Reduced 59.75%	46,889 $107,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.94 $192,826 - $491,582	82,758 Added 245.39%	116,483 $271,000
Q3 2021 Nov 15, 2021	BUY	$5.89 - $9.35 $198,640 - $315,328	33,725 New	33,725 $198,000

Others Institutions Holding HOOK

# of Institutions

Shares Held

32.5M

Call Options Held

105K

Put Options Held

43.6K

View Full List

About HOOKIPA Pharma Inc.

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $33.1M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

More about HOOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account